Page 6 - Specialized Program News Today

The director of education for the Ottawa-Carleton District School Board says making sure elementary school students can attend classes close to home is an important part of making schooling in Ottawa more equitable.

Cybersecurity giant Cisco said on Wednesday it has partnered with the Bankers Association of the Philippines (BAP) to “elevate” the cybersecurity knowledge and skills of professionals within the commercial banking sphere. Implemented under Cisco’s Country Digital Acceleration Program, the “Cisco-BAP Cybersecurity Skills Training Program for the Next Generation Banker” saw…

Molecular Mechanisms and Translational Cancer Research job in Dallas, Texas (US) with The University of Texas Southwestern Medical Center (UT Southwestern Medical Center). Apply Today.

William Hawkins, MD, will join MUSC Hollings Cancer Center on January 1, 2024, as deputy director, where he will focus on strengthening translational research, increasing clinical trials across South Carolina and assisting Craig Lockhart, MD, with making clinical operations more efficient.

Molecular Mechanisms and Translational Cancer Research job in Lake Dallas, Texas (US) with The University of Texas Southwestern Medical Center (UT Southwestern Medical Center). Apply Today.

University of Hawai‘i Cancer Center researchers Loïc Le Marchand and Jeffrey Berenberg will lead the development of the first Specialized Program of Research Excellence (SPORE) in Hawaiʻi that will focus on conducting public impact research that bridge the gap between scientific discoveries and their real-world applications, primarily focusing on local ethnic groups.

UH Cancer Center researchers will develop the first Specialized Program of Research Excellence in Hawaiʻi to address cancer health disparities.

Investors often find stocks with momentum attractive because they have shown a recent trend of strong performance. The belief is that this trend may continue, offering the potential for profitable...

When combined with Keytruda, the novel drug, NC318, proved to be safe and efficacious in treating advanced non-small cell lung cancer, research showed.

Investors often follow stocks that gain momentum, and for good reason. These stocks tend to maintain their direction for a while, presenting opportunities for quick gains. In this feature, well take...